Bio

Mr. Spaight is an Operating Partner of Arsenal for the healthcare team. Prior to joining Arsenal in 2016, Mr. Spaight served as the Chairman and CEO of WIL Research Laboratories, a leading pre-clinical (“CRO”) acquired by Charles River Laboratories. Prior to WIL, he served as President of MDS Pharma Services, a global CRO serving all phases of pharmaceutical research and development, from early discovery to late-stage clinical trials and central laboratory support. Prior to MDS, he held senior leadership positions in Fisher Scientific Products and PerkinElmer. M.B.A., University of Michigan; B.S., University of Michigan;